【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Erectile Dysfunction Overview 9
Therapeutics Development 10
Pipeline Products for Erectile Dysfunction – Overview 10
Pipeline Products for Erectile Dysfunction – Comparative Analysis 11
Erectile Dysfunction – Therapeutics under Development by Companies 12
Erectile Dysfunction – Therapeutics under Investigation by Universities/Institutes 14
Erectile Dysfunction – Pipeline Products Glance 15
Late Stage Products 15
Clinical Stage Products 16
Early Stage Products 17
Unknown Stage Products 18
Erectile Dysfunction – Products under Development by Companies 19
Erectile Dysfunction – Products under Investigation by Universities/Institutes 21
Erectile Dysfunction – Companies Involved in Therapeutics Development 22
Acorda Therapeutics, Inc. 22
Apricus Biosciences, Inc. 23
Aprogen, Inc. 24
Bioheart, Inc. 25
Biolab Sanus Farmaceutica Ltda. 26
Corridor Pharmaceuticals Inc. 27
Furiex Pharmaceuticals, Inc. 28
Futura Medical plc 29
Hanmi Pharmaceuticals, Co. Ltd. 30
IntelGenx Corp. 31
Mezzion Pharma Co. Ltd. 32
Mitsubishi Tanabe Pharma Corporation 33
NAL Pharmaceuticals Ltd. 34
Pacific Therapeutics Ltd. 35
Palatin Technologies, Inc. 36
Pharmicell Co., Ltd. 37
Sagene Pharmaceuticals, Inc. 38
Suda Ltd 39
Yungjin Pharm Ind. Co., Ltd. 40
Erectile Dysfunction – Therapeutics Assessment 41
Assessment by Monotherapy Products 41
Assessment by Combination Products 42
Assessment by Target 43
Assessment by Mechanism of Action 45
Assessment by Route of Administration 47
Assessment by Molecule Type 49
Drug Profiles 51
AdipoCell – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
alprostadil – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
AP-102 – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
BL-214 – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
cimaglermin alfa – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
dapoxetine hydrochloride – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
HCP-1302 – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
HCP-1303 – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
Immpocellgram – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
MED-2002 – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
Next Generation Melanocortin Receptor IV Agonist – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
Peptide to Activate G Protein-Coupled Receptor Mas for Cardiovascular, Metabolic Disorders and Erectile Dysfunction – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
PL-6983 – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
selegiline + PDE-5 Inhibitor – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
sildenafil citrate – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
sildenafil citrate – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
sildenafil citrate – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
Small Molecule to Inhibit Arginase for Vascular Dysfunction, PAH and Erectile Dysfunction – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
T-6932 – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
tadalafil – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
tadalafil – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
TPN-729 – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
udenafil – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
YBH-1603 – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
Erectile Dysfunction – Recent Pipeline Updates 83
Erectile Dysfunction – Dormant Projects 94
Erectile Dysfunction – Discontinued Products 97
Erectile Dysfunction – Product Development Milestones 98
Featured News & Press Releases 98
Feb 24, 2014: IntelGenx Achieves Positive Bioequivalence Results for Erectile Dysfunction VersaFilm Tadalafil Product 98
Aug 28, 2012: Acorda Announces GGF2 Preclinical Data On Treatment Of Erectile Dysfunction 98
Jul 18, 2012: Zydus Urosciences Launches Udenafil For Treatment Of Erectile Dysfunction In India 99
Sep 08, 2011: Sagene Completes Pre-IND Meeting With FDA For Dual-Action Erectile Dysfunction Drug 99
Oct 12, 2010: Dong-A Launches Zydena For Daily Treatment Of Erectile Dysfunction In Korea 100
Sep 02, 2010: IntelGenx Achieves Positive Bioequivalence Results For Erectile Dysfunction Film Product 100
Nov 19, 2009: Once-A-Day Dosing Clinical Study Of Udenafil For Erectile Dysfunction Completed By Dong-A Pharmaceutical Co., Ltd. 100
Nov 11, 2009: ZYDENA Poised To Enter Global Market With Phase III Clinical Trial Starting For US FDA Approval 101
Sep 11, 2009: New Drug Udenafil By Dong-A PharmTech Co. Ltd For Erectile Dysfunction in US Trials 102
Aug 28, 2009: Dong-A Receives Approval For Zydena For Treatment Of Erectile Dysfunction 102
Appendix 103
Methodology 103
Coverage 103
Secondary Research 103
Primary Research 103
Expert Panel Validation 103
Contact Us 104
Disclaimer 104
【レポート販売概要】
■ タイトル：勃起不全(Erectile Dysfunction)の治療薬パイプライン動向（2015年上半期版）■ 英文：Erectile Dysfunction - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6047IDB
■ 調査対象地域：グローバル
- 代謝性アシドーシス（Metabolic Acidosis）：グローバル臨床試験レビュー（2014年上半期）Metabolic Acidosis Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metabolic Acidosis Global Clinical Trials Review, H1, 2014" provides data on the Metabolic Acidosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metabolic Acidosis. It includes an overview of the trial numbers and their recruitme …
- 世界のバイオフォトニクス（Biophotonics）市場動向（2012-2016）TechNavio's analysts forecast the Global Biophotonics market to grow at a CAGR of 10.03 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Biophotonics market has also been witnessing the expansion of application. However, the high cost could pose a challenge to the growth of this market. TechNavio's report, t …
- 硫酸の世界市場2015-2019About Sulfuric Acid Sulfuric acid is a colorless, viscous liquid; it is hazardous and corrosive in nature. Sulfur is the major raw material used in the production of sulfuric acid, and around 90 percent of global sulfur production is used in the sulfuric acid production. The other methods of sulfuric acid production include production from smelter gas and iron pyrites. Sulfuric acid finds its appl …
- 企業資産管理ソフトウェアの世界市場予測（～2021）MarketsandMarkets forecasts the Enterprise Asset Management (EAM) market size to grow from USD 3.15 Billion in 2016 to USD 5.24 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 10.7%. Improved return on assets and the need to enhance the asset life of rapidly aging infrastructure are some of the key factors driving the EAM market. Other driving forces include the growing need for operat …
- グローバルにおけるオンライン小売（インターネット通販）市場動向With an increase in the adoption of social media around the world, there has been tremendous growth in the global online retail industry. Shoppers today are tending to shop online more and more often than ever before. Instead of having to wait in checkout lines or maneuver around a crowded shopping center, people prefer to shop from the comfort of their own home. With online companies aiming to at …
- 分散データグリッドの世界市場2015-2019About distributed data grid Distributed data grids are data storage software. They represent a sub-segment of in-memory computing. Data grids store data in the RAMs of a set of multiple servers distributed across various locations, which can be managed centrally. Distributed data grids are versatile as they can store both structured as well as unstructured data. Distributed data grids have several …
- 世界におけるLAG-3アンタゴニストのパイプライン分析2015Summary DelveInsight’s, LAG-3 Antagonist- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the LAG-3 Antagonist. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The LAG-3 Antagonist Report helps to identify emerging players with potentially s …
- フタル酸ジオクチル(DOP)の世界市場予測Dioctyl Phthalate (DOP) 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about Dioctyl Phthalate (DOP) market in the all-in-one report issued in a logical and easily accessible format. In addition …
- 日本の石油・ガス産業における中流（Midstream）市場展望Japan Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines, Underground Gas Storage and Gas Processing Summary "Japan Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines, Underground Gas Storage and Gas Processing" is a comprehensive report on midstream oil and g …
- コンタクトセンターソリューションの世界市場2015-2019About contact center Business enterprises worldwide have become increasingly dependent on various technologies and the Internet to run their business and drive revenue growth. This trend is expected to intensify, which indicates that the role of IT has become vital and directly contributes to the organization’s agenda. Contact center is s facility used to manage clients or customers contact via em …
- データセンター用サーバーの世界市場2017-2021About Data Center Server Servers are the backbone of a data center operation, and they are used mainly for the transfer of data over computer networks. A server operation is dependent on hardware reliability and durability. A typical server consists of dual-power supplies, redundant array of independent disks (RAID) disk systems, and error-correcting code (ECC) memory, which are tested for operati …
- 質量分析装置の世界市場：三連四重極質量分析法、TOF質量分析法、イオントラップ質量分析法About Mass Spectrometry Mass spectrometry is a technique commonly employed in chemistry to ascertain the amount and type of chemicals present in a test sample. This is done by measuring the mass-to-charge ratio and the abundance of gas phase ions in the sample. The estimation of the mass-to-charge proportion is made on the premise of a mass range, which is a plotted form of the particle signals. T …
- OTC医薬品（一般用医薬品）の世界市場World OTC pharmaceuticals – your guide to technologies, trends and revenues Where is the world OTC pharmaceutical market heading? Visiongain’s new report gives you revenue, trends, opportunities, helping you stay ahead. Our 245-page report provides 154 tables, charts, and graphs. Discover the growing trends of this industry. In particular, our new study lets you assess forecasted sales of the over …
- PTFE (ポリテトラフルオロエチレン) ファブリックの世界市場予測（～2023年）“In terms of value, the PTFE fabric market is projected to grow at a CAGR of 5.6% from 2018 to 2023” The PTFE fabric market is projected to grow from USD 690.8 million in 2018 to USD 908.1 million by 2023, at a CAGR of 5.6% from 2018 to 2023. High demand for PTFE fabrics in the automotive industry, their growing demand in the construction industry, and increasing consumption of composite fabrics f …
- アレルゲン免疫療法の世界市場2019-2023112 pages, November 2018 About this market The emerging drug development technologies is likely to help the market grow during the forecast period. The recent advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more efficient immunotherapies for the treatment of various allergies. Technavio’s analysts have predicted that the allergy immunotherapies ma …
